Standout Papers

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer 2002 2026 2010 2018 4.0k
  1. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer (2002)
    Joan H. Schiller, David Harrington et al. New England Journal of Medicine
  2. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer (2015)
    Martin Schlumberger, Makoto Tahara et al. New England Journal of Medicine
  3. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival (2009)
    James A. Bonner, Paul M. Harari et al. The Lancet Oncology

Immediate Impact

2 by Nobel laureates 7 from Science/Nature 94 standout
Sub-graph 1 of 13

Citing Papers

Thyroid Cancer
2024 Standout
Thyroid cancer
2023 Standout

Works of Junming Zhu being referenced

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout

Author Peers

Author Last Decade Papers Cites
Junming Zhu 4224 923 105 4079 1795 27 7.2k
James R. Egner 1719 1775 71 2215 761 21 4.9k
Frederick L. Greene 2125 2408 86 3677 859 43 6.6k
Steven D. Averbuch 7370 984 62 7926 2824 57 10.9k
Otilia Dalesio 3819 1402 116 4373 1472 103 7.9k
Donna M. Gress 2009 1994 73 2405 677 11 5.3k
Renato Martins 4717 362 33 4841 1810 40 6.9k
Tarek Sahmoud 4830 3016 90 5060 2034 129 11.1k
Dorothy J. Giroux 5612 862 73 2187 659 39 7.1k
Jean-Pascal Machiels 2365 443 20 1999 942 36 4.4k
Yue Shentu 6838 983 62 10488 1276 34 12.3k

All Works

Loading papers...

Rankless by CCL
2026